MNMD LONG

Breakout, CHoCH, volume supporting the move, 20.82 target, march Opex expiration. nothing big, I like the setup. why are we running tho??

The confirmation of Robert F. Kennedy Jr. as the head of the U.S. Department of Health and Human Services could have a positive impact on biotech stocks, particularly in the psychedelic space. RFK Jr.'s support for mental health treatments using psychedelics like those being developed by Mind Medicine (MNMD) aligns with a potential shift in policy towards chronic disease prevention and alternative therapies. Analysts believe this could boost biotech companies focused on psychedelics, such as MNMD, which saw a slight uptick in stock following his confirmation.